Singular Health Group Ltd

Singular Health Group Ltd

SHG · AU · Healthcare / Health Information Services

0.195AUD-0.01 (-4.88%)

Price History

Full chart

Market Stats

Previous Close0.205
Open0.195
Day Range0.195 – 0.21
52-Week Range0.17 – 0.345
Volume481.95K
Market Cap60.33M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.02
Dividend Yield0.00%
Beta-0.03
50-Day Avg0.1866
200-Day Avg0.216

About

Singular Health Group Ltd, operates as a healthcare technology company in Australia. The company Volumetric Rendering Platform, a proprietary technology that enhances the visualization of patient anatomy and health issues by converting 2D images from CT, MRI, and PET scans into 3D models. It also provides Medical File Transfer Protocol, a technology that streamlines the access, sharing, and storage of medical images, such as CT, MRI, and PET scans across electronic devices and healthcare providers. In addition, the company offers AI in the Cloud that enhances medical imaging by integrating AI models. Further, it provides 3DICOM MD for healthcare professionals; 3DICOM EDU and XR for academics and researchers; and 3DICOM Patient for patients. Additionally, the company is involved in development and commercialization of the 3DICOM platform; enterprise healthcare imaging/interoperability solutions; education applications; and associated regulatory and product-development activities. Singular Health Group Ltd was incorporated in 2020 and is based in Leederville, Australia.

Company Details

  • SectorHealthcare
  • IndustryHealth Information Services
  • CEOMr. Denning Chong
  • Employees0
  • HeadquartersE3/661 Newcastle Stree, Leederville, WA, Australia, 6007, Australia
  • Websitehttps://singular.health

Leadership

  • Mr. Denning ChongCo-Founder, MD, CEO & Executive Director
  • Dr. Martina MarianoChief Operating Officer
  • Ms. Paige TaylorChief Commercial Officer
  • Ms. Kyla Garic B.Com., C.A.Chief Financial Officer
  • Mr. Steven Douglas Wood B.Com., C.A.Company Secretary

Financials

Income Statement

Currency: AUD2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue103.86K193.64K54.03K28.12K934.07K557.61K1.43M
Growth (%)-+86.44%-72.10%-47.95%+3221.51%-40.30%+156.14%
Cost of Revenue773.25K1.81M2.16M4.20M417.71K643.83K5.45M
Gross Profit-669.39K-1.62M-2.11M-3.58M516.36K-86.22K-4.02M
Gross Margin-644.48%-835.16%-3896.72%-12739.26%55.28%-15.46%-281.49%
Operating Expense41.28M4.15M1.19M3.38M6.11M2.75M
Operating Income-669.39K-2.90M-6.25M-4.77M-2.86M-6.20M-6.77M
Operating Margin-644.48%-1498.12%-11571.29%-16958.47%-306.66%-1111.61%-474.34%
EBITDA-620.58K-2.86M-5.65M-4.52M-2.58M-6.27M-6.69M
EBITDA Margin-597.49%-1477.47%-10461.79%-16085.45%-276.50%-1123.80%-468.67%
Net Income-707.59K-4.46M-5.99M-5.39M-4.92M-6.38M-6.34M
Net Income Margin-681.26%-2301.19%-11078.25%-19167.62%-527.23%-1143.49%-443.94%
R&D-335.63K598.04K587.74K417.71K289.29K715.75K
R&D as % of Total Revenue-173.33%1106.78%2089.97%44.72%51.88%50.11%
Interest Expense54.61K1.46M12.89K477.62K97.79K10.42K9.90K
Interest Expense % of Total Revenue52.58%756.23%23.85%1698.39%10.47%1.87%0.69%

Balance Sheet

Currency: AUD2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets668.27K5.43M2.14M3.00M2.35M14.21M11.24M
Total Liabilities881.86K345.10K391.50K2.94M909.59K1.11M699.20K
Total Equity-213.59K5.08M1.75M61.89K1.44M13.10M10.54M
Cash130.55K4.14M1.14M691.51K1.45M13.68M2.36M
Total Debt745.94K147.59K85.66K2.51M218.45K-109.96K
Net Debt615.39K-3.99M-1.05M1.82M-1.23M-13.68M-2.25M

Cash Flow

Currency: AUD2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-548.17K-1.91M-2.91M-2.46M-2.44M-2.34M-5.30M
Investing Cash Flow-259.31K-610.57K-17.12K-635.21K-3.56K88.14K5.37M
Financing Cash Flow950.69K6.52M-69.25K2.65M3.21M14.48M1.67M
Capital Expenditure259.31K310.57K11.78K22.49K73.56K29.16K143.84K
Free Cash Flow-807.48K-2.22M-2.92M-2.49M-2.51M-2.37M-5.45M
FCF to OCF147.30%116.28%100.41%100.91%103.01%101.25%102.71%

Earnings

Report DateFeb 26, 2021Sep 30, 2021Feb 24, 2022Aug 31, 2022Feb 24, 2023Feb 28, 2025Aug 29, 2025
EPS Estimate0.000.000.000.000.000.000.00
EPS Actual-0.04-0.03-0.03-0.03-0.03-0.01-0.01
Surprise-------
Timing-------

Key Statistics & Ratios

Market Cap60.33M
Enterprise Value50.37M
Trailing P/E0.00
Forward P/E0.00
Price / Sales31.75
Price / Book5.73
EPS-0.02
Book Value0.033
Revenue (TTM)1.90M
Gross Profit (TTM)712.48K
EBITDA-6.69M
Profit Margin0.00%
Operating Margin-248.86%
Return on Equity-53.66%
Return on Assets-33.28%
Shares Outstanding326.09M
Shares Float227.49M
Beta-0.03
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%